Clinical Trial Update: Effect of Chronic PDE5-Inhibition on Endothelial Function in Diabetics [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating chronic PDE5 inhibition on endothelial function in diabetics has completed. The update summarizes completion rather than presenting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• PDE5 inhibitor (unspecified)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Diabetes | Phase 3 | Status: COMPLETED